Skip to main content
. 2010 Nov 17;5(11):e14024. doi: 10.1371/journal.pone.0014024

Figure 2. Cumulative incidence of therapeutic progression by addition of an antidiabetic treatment or switch to any antidiabetic medicine.

Figure 2

The plain line represents the cumulative incidence of therapeutic progression by addition of an antidiabetic treatment or switch to any antidiabetic medicine. The dash line represents the cumulative incidence of the competing risk event, death, occurring prior to therapeutic progression.